Please use this identifier to cite or link to this item:
http://hdl.handle.net/2080/3907
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Praharaj, Prakash P. | - |
dc.contributor.author | Bhutia, Sujit K. | - |
dc.date.accessioned | 2023-01-16T05:52:02Z | - |
dc.date.available | 2023-01-16T05:52:02Z | - |
dc.date.issued | 2022-12 | - |
dc.identifier.citation | International Conference on Recent Advances in Biological Sciences -2022 (RABS-2022), Vikram Deb Autonomous College, Jeypore, Odisha, India, 23-24 December 2022 | en_US |
dc.identifier.uri | http://hdl.handle.net/2080/3907 | - |
dc.description | Copyright belongs to proceeding publisher | en_US |
dc.description.abstract | Autophagy affects tumorigenicity and malignancy by regulating cancer stem cell (CSCs) populations. In this study, we demonstrate that cisplatin treatment increases autophagosome formation and speeds up autophagosome-lysosome fusion, thus enriching the CSCs population. An intriguing discovery is that cisplatin treatment boosts autophagic flux by increasing lysosomal activity. In addition, both ATG5 and BECN1 are required for autophagy activation, which is critical for cancer stemness, self-renewal, and cisplatin cytotoxicity in CD44+ cells. Pharmacological inhibition of autophagy (chloroquine; 20 µM; 3 h) increases ROS production, which in turn enhances cisplatin-driven apoptosis in CD44+ CSCs. Further, we showed that cisplatin treatment activates NRF2 (nuclear factor, erythroid 2 like 2) signaling in autophagy-deficient CSCs, which in turn decreases the elevated ROS level and improves cancer stemness. Finally, silencing NRF2 with siNRF2 (a genetic approach) or ML-385 (a pharmacological inhibitor of NRF2) decreased cancer stemness in autophagy-deficient CD44+ cells. Inhibiting autophagy (using CQ) and NRF2 (using ML-385) simultaneously increased cisplatin-induced cytotoxicity and suppressed the expansion of oral CSCs, which may help treat CSC-associated drug resistance and tumor relapse in oral cancer. | en_US |
dc.subject | Autophagy | en_US |
dc.subject | apoptosis | en_US |
dc.subject | cancer stem cell | en_US |
dc.subject | NRF2 | en_US |
dc.subject | oral cancer | en_US |
dc.subject | mtROS | en_US |
dc.title | Autophagy and NRF2 antioxidant signaling are co-targeted to selectively sensitize cancer stem cells to apoptosis | en_US |
dc.type | Presentation | en_US |
Appears in Collections: | Conference Papers |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
2022 _RABS_PPraharaj_Autophagy.pdf | 4.92 MB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.